Different Models of Chemotherapy Taking Into Account Drug Resistance Stemming from Gene Amplification

• Autorzy: Śmieja J. , Świerniak A.
• Języki publikacji: EN

Abstrakty

EN

This paper presents an analysis of some class of bilinear systems that can be applied to biomedical modelling. It combines models that have been studied separately so far, taking into account both the phenomenon of gene amplification and multidrug chemotherapy in their different aspects. The mathematical description is given by an infinite dimensional state equation with a system matrix whose form allows decomposing the model into two interacting subsystems. While the first one, of a finite dimension, can have any form, the other is infinite dimensional and tridiagonal. A methodology of the analysis of such models, based on system decomposition, is presented. An optimal control problem is defined in the l1 space. In order to derive necessary conditions for optimal control, the model description is transformed into an integro-differential form. Finally, biomedical implications of the obtained results are discussed.

Słowa kluczowe

EN

biomedical modelling; infinite dimensional systems; multivariable control

PL

modelowanie biomedyczne; układ nieskończenie wymiarowy; sterowanie wielowymiarowe

• Wydawca: Oficyna Wydawnicza Uniwersytetu Zielonogórskiego
• Czasopismo: International Journal of Applied Mathematics and Computer Science
• Rocznik: 2003
• Tom: Vol. 13, no 3
• Strony: 297--305
• Opis fizyczny: Bibliogr 25 poz.., rys.

Twórcy

autor

Śmieja J.

• Department of Automatic Control, Silesian University of Technology, ul. Akademicka 16, 44–100 Gliwice, Poland

autor

Świerniak A.

• Department of Automatic Control, Silesian University of Technology, ul. Akademicka 16, 44–100 Gliwice, Poland

Bibliografia

• [1] Arino O., Kimmel M. and Webb G.F. (1995): Mathematical modelling of the loss of telomere sequences. — J. Theor. Biol., Vol. 177, No. 1, pp. 45–57.
• [2] Axelrod D.E., Baggerly K.A. and Kimmel M. (1994): Gene amplification by unequal chromatid exchange: Probabilistic modelling and analysis of drug resistance data. — J. Theor. Biol., Vol. 168, No. 2, pp. 151–159.
• [3] Bate R.R. (1969): The optimal control of systems with transport lag, In: Advances in Control and Dynamic Systems (C.T. Leondes, Ed.).—Academic Press, Vol. 7, pp. 165–224.
• [4] Brown B.W. and Thompson J.R. (1975): A rationale for synchrony strategies in chemotherapy, In: Epidemiology (D. Ludwig and K.L. Cooke, Eds.). — Philadelphia: SIAM Publ., pp. 31–48.
• [5] Coldman A.J. and Goldie J.H. (1986): A stochastic model for the origin and treatment of tumors containing drug-resistant cells.—Bull. Math. Biol., Vol. 48, No. 3–4, pp. 279–292.
• [6] Connor M.A. (1972): Optimal control of systems represented by differential-integral equations. — IEEE Trans. Automat. Contr., Vol. AC-17, No. 1, pp. 164–166.
• [7] Curtain R.F. and Zwart H.J. (1995): An Introduction to Infinite-Dimensional Linear Systems Theory. — New York: Springer.
• [8] Gabasov R. and Kirilowa F.M. (1971): Qualitative theory of optimal processes.—Moscow: Nauka, (in Russian).
• [9] Harnevo L.E. and Agur Z. (1993): Use of mathematical models for understanding the dynamics of gene amplification. — Mutat. Res., Vol. 292, No. 1, pp. 17–24.
• [10] Kimmel M. and Axelrod D.E. (1990): Mathematical models of gene amplification with applications to cellular drug resistance and tumorigenicity. — Genetics, Vol. 125, No. 3, pp. 633–644.
• [11] Kleinrock L. (1976): Queuing Systems. Vol. 1: Theory. — New York: Wiley.
• [12] Olofsson P. and Kimmel M. (1999): Stochastic models of telomere shortening. — Math. Biosci., Vol. 158, No. 1, pp. 75–92.
• [13] Polański A., Kimmel M. and Świerniak A. (1997): Qualitative analysis of the infinite-dimensional model of evolution of drug resistance, In: Advances in Mathematical Population Dynamics—Molecules, Cells and Man (O. Arino, D. Axelrod and M. Kimmel, Eds.). — Singapore: World Scientific, pp. 595–612.
• [14] Pontryagin L.S., Boltyanski V.G., Gamkrelidze R.V. and Mischenko E.F. (1962): Mathematical Theory of Optimal Processes.— New York: Wiley.
• [15] Ramel C. (1997): Mini- and microsatellites. — Environmental Health Perspectives, Vol. 105, Suppl. 104, pp. 781–789.
• [16] Śmieja J., Duda Z. and Świerniak A. (1999): Optimal control for the model of drug resistance resulting from gene amplification. — Prep. 14th IFAC World Congress, Beijing, China, Vol. L, pp. 71–75.
• [17] Śmieja J., Świerniak A. and Duda Z. (2000): Gradient method for finding optimal scheduling in infinite dimensional models of chemotherapy. — J. Theor. Med., Vol. 3, No. 1, pp. 25–36.
• [18] Swan G.W. (1990): Role of optimal control theory in cancer chemotherapy.—Math. Biosci., Vol. 101, No. 2, pp. 237–284.
• [19] Świerniak A., Śmieja J., Rzeszowska-Wolny J. and Kimmel M. (2001): Random branching walk models arising in molecular biology—control theoretic approach. — Proc. IASTED MIC Conf., Innsbruck, Austria, Vol. II, pp. 584–589.
• [20] Świerniak A., Kimmel M., Polański A. and Śmieja J. (1997a): Asymptotic properties of infinite dimensional model of drug resistance evolution.—Proc. ECC’97, Brussels, TUA- C-4, CD-ROM.
• [21] Świerniak A., Polański A., Duda Z. and Kimmel M. (1997b): Phase-specific chemotherapy of cancer: Optimisation of scheduling and rationale for periodic protocols.—Biocybern. Biomed. Eng., Vol. 16, No. 1–2, pp. 13–43.
• [22] Świerniak A., Kimmel M. and Polański A. (1998): Infinite dimensional model of evolution of drug resistance of cancer cells. — J. Math. Syst. Estim. Contr., Vol. 8, No. 1, pp. 1–17.
• [23] Świerniak A., Polański A., Kimmel M., Bobrowski A. and Śmieja J. (1999): Qualitative analysis of controlled drug resistance model—inverse Laplace and semigroup approach. — Contr. Cybern., Vol. 28, No. 1, pp. 61–74.
• [24] Świerniak A., Polański A., Śmieja J., Kimmel M. and Rzeszowska-Wolny J. (2002): Control theoretic approach to random branching walk models arising in molecular biology.— Proc. ACC Conf., Anchorage, pp. 3449–3453.
• [25] Zadeh L.A. and Desoer C.A. (1963): Linear System Theory. The State Space Approach.—New York: McGraw-Hill.